Cargando…
Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling
BACKGROUND: Bladder cancer (BLCA) is the fifth most common type of cancer worldwide, with high recurrence and progression rates. Although considerable progress has been made in the treatment of BLCA through accurate typing of molecular characteristics, little is known regarding the various genetic a...
Autores principales: | Tang, Chaozhi, Ma, Jiakang, Liu, Xiuli, Liu, Zhengchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594303/ https://www.ncbi.nlm.nih.gov/pubmed/33115513 http://dx.doi.org/10.1186/s13287-020-01973-4 |
Ejemplares similares
-
Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene Sets
por: Tang, Chaozhi, et al.
Publicado: (2020) -
Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma
por: Tang, Chaozhi, et al.
Publicado: (2020) -
Metabolic classification of bladder cancer based on multi-omics integrated analysis to predict patient prognosis and treatment response
por: Tang, Chaozhi, et al.
Publicado: (2021) -
Identification of stem cell-related subtypes and risk scoring for gastric cancer based on stem genomic profiling
por: Xiang, Renshen, et al.
Publicado: (2021) -
Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling
por: Wang, Hongzhi, et al.
Publicado: (2021)